Insider Trading activities at Antares Pharma, Inc. (AIS)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Antares Pharma, Inc. (AIS) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Antares Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1016169.

Total stock buying since 2014: $1,243,405.
Total stock sales since 2014: $31,579,333.
Total stock option exercises since 2014: $3,542,698.


13 insiders reported insider trading activities at Antares Pharma, Inc. (AIS):
Insider trading activities of Hobbs Eamonn P
Insider trading activities of Apple Robert F
Insider trading activities of Graham Peter J
Insider trading activities of Garrity Thomas J
Insider trading activities of Fickenscher James E
Insider trading activities of Gonella Jacques
Insider trading activities of Jacob Leonard S
Insider trading activities of Roche Robert P Jr
Insider trading activities of Deerfield International Master Fund, L.p.
Insider trading activities of Gueth Anton
Insider trading activities of Powell Fred M
Insider trading activities of Deerfield Special Situations Fund, L.p.
Insider trading activities of Samson Marvin

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Antares Pharma, Inc. (AIS).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2021 0 $0 917,781 $4,374,569 615,821 $850,926
2020 16,400 $46,740 100,000 $459,694 100,000 $234,016
2019 0 $0 1,163,416 $5,005,134 1,008,602 $1,774,814
2018 0 $0 2,623,306 $7,405,689 187,907 $143,380
2017 130,000 $363,220 371,762 $1,364,762 450,362 $480,762
2016 645,000 $595,900 0 $0 0 $0
2015 10,000 $18,550 6,114,692 $12,969,485 20,000 $30,800
2014 99,000 $218,995 0 $0 20,000 $28,000

Table 2. Monthly summary of insider trading at Antares Pharma, Inc. (AIS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2021-07 0 $0 100,000 $429,000 0 $0
2021-05 0 $0 0 $0 40,000 $66,400
2021-03 0 $0 50,000 $214,000 50,000 $56,000
2021-02 0 $0 697,781 $3,447,369 455,821 $610,926
2021-01 0 $0 70,000 $284,200 70,000 $117,600
2020-11 16,400 $46,740 0 $0 0 $0
2020-01 0 $0 100,000 $459,694 100,000 $234,016
2019-12 0 $0 841,338 $3,918,920 756,524 $1,567,113
2019-11 0 $0 0 $0 110,000 $121,000
2019-10 0 $0 0 $0 20,000 $22,000
2019-05 0 $0 30,000 $79,980 30,000 $15,900
2019-04 0 $0 92,078 $276,234 92,078 $48,801
2019-02 0 $0 200,000 $730,000 0 $0
2018-10 0 $0 400,000 $1,516,000 0 $0
2018-08 0 $0 343,000 $1,088,249 43,000 $20,210
2018-06 0 $0 659,244 $1,758,202 0 $0
2018-05 0 $0 1,221,062 $3,043,238 112,500 $95,625
2018-03 0 $0 0 $0 32,407 $27,545
2017-12 0 $0 0 $0 60,000 $73,800
2017-10 0 $0 260,000 $1,036,730 248,600 $173,055
2017-06 130,000 $363,220 0 $0 0 $0
2017-04 0 $0 81,762 $240,762 81,762 $134,907
2017-03 0 $0 30,000 $87,270 60,000 $99,000
2016-12 100,000 $202,500 0 $0 0 $0

Table 3. Detailed insider trading at Antares Pharma, Inc. (AIS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2021-07-08 Gueth Anton (Director) Sale 100,000 4.29 429,000
2021-05-04 Gueth Anton (Director) Option Ex 40,000 1.66 66,400
2021-03-11 Garrity Thomas J (Director) Sale 50,000 4.28 214,000
2021-03-11 Garrity Thomas J (Director) Option Ex 50,000 1.12 56,000
2021-02-18 Graham Peter J (EVP General Counsel, Secretary) Sale 45,000 4.98 224,100
2021-02-18 Graham Peter J (EVP General Counsel, Secretary) Option Ex 45,000 1.12 50,400
2021-02-18 Apple Robert F (President & CEO) Sale 491,960 5.00 2,461,275
2021-02-18 Apple Robert F (President & CEO) Option Ex 250,000 .88 220,000
2021-02-18 Jacob Leonard S (Director) Sale 15,321 5.05 77,371
2021-02-18 Jacob Leonard S (Director) Option Ex 15,321 2.24 34,319
2021-02-17 Apple Robert F (President & CEO) Sale 5,519 4.75 26,215
2021-02-17 Apple Robert F (President & CEO) Option Ex 5,519 2.62 14,459
2021-02-11 Garrity Thomas J (Director) Sale 50,000 4.62 231,000
2021-02-11 Garrity Thomas J (Director) Option Ex 50,000 1.12 56,000
2021-02-10 Apple Robert F (President & CEO) Sale 7,278 4.75 34,570
2021-02-10 Apple Robert F (President & CEO) Option Ex 7,278 2.62 19,068
2021-02-09 Apple Robert F (President & CEO) Sale 49,129 4.75 233,362
2021-02-09 Apple Robert F (President & CEO) Option Ex 49,129 2.62 128,717
2021-02-08 Apple Robert F (President & CEO) Sale 33,574 4.75 159,476
2021-02-08 Apple Robert F (President & CEO) Option Ex 33,574 2.62 87,963
2021-01-11 Garrity Thomas J (Director) Sale 70,000 4.06 284,200
2021-01-11 Garrity Thomas J (Director) Option Ex 70,000 1.68 117,600
2020-11-12 Powell Fred M (Executive Vice President & CFO) Buy 16,400 2.85 46,740
2020-01-10 Samson Marvin (Director) Sale 56 4.50 252
2020-01-10 Samson Marvin (Director) Option Ex 56 2.66 148
2020-01-02 Samson Marvin (Director) Sale 99,944 4.60 459,442
2020-01-02 Samson Marvin (Director) Option Ex 99,944 2.34 233,868
2019-12-23 Samson Marvin (Director) Sale 150,000 4.71 706,500
2019-12-23 Samson Marvin (Director) Option Ex 150,000 1.12 168,000
2019-12-10 Apple Robert F (President & CEO) Sale 58,524 4.76 278,340
2019-12-10 Apple Robert F (President & CEO) Option Ex 58,524 3.96 231,755
2019-12-09 Garrity Thomas J (Director) Sale 80,000 4.58 366,480
2019-12-09 Garrity Thomas J (Director) Option Ex 80,000 1.63 130,399
2019-12-09 Apple Robert F (President & CEO) Sale 308,000 4.66 1,434,356
2019-12-09 Apple Robert F (President & CEO) Option Ex 308,000 2.52 776,160
2019-12-09 Jacob Leonard S (Director) Sale 244,814 4.63 1,133,244
2019-12-09 Jacob Leonard S (Director) Option Ex 160,000 1.63 260,799
2019-11-11 Apple Robert F (President & CEO) Option Ex 100,000 1.10 110,000
2019-11-01 Garrity Thomas J (Director) Option Ex 10,000 1.10 11,000
2019-10-31 Jacob Leonard S (Director) Option Ex 20,000 1.10 22,000
2019-05-01 Garrity Thomas J (Director) Sale 30,000 2.67 79,980
2019-05-01 Garrity Thomas J (Director) Option Ex 30,000 .53 15,900
2019-04-08 Jacob Leonard S (Director) Sale 92,078 3.00 276,234
2019-04-08 Jacob Leonard S (Director) Option Ex 92,078 .53 48,801
2019-02-26 Gonella Jacques (Director) Sale 200,000 3.65 730,000
2018-10-02 Gonella Jacques (Director) Sale 400,000 3.79 1,516,000
2018-08-21 Apple Robert F (President & CEO) Sale 43,000 3.75 161,250
2018-08-21 Apple Robert F (President & CEO) Option Ex 43,000 .47 20,210
2018-08-13 Gonella Jacques (Director) Sale 49,507 3.09 152,976
2018-08-08 Gonella Jacques (Director) Sale 250,493 3.09 774,023
2018-06-15 Gonella Jacques (Director) Sale 565 2.95 1,666
2018-06-12 Gonella Jacques (Director) Sale 100,000 2.77 277,000
2018-06-11 Gonella Jacques (Director) Sale 100,000 2.69 269,000
2018-06-06 Gonella Jacques (Director) Sale 20,259 2.70 54,699
2018-06-05 Gonella Jacques (Director) Sale 123,129 2.62 317,447
2018-06-04 Gonella Jacques (Director) Sale 100,000 2.65 265,000
2018-06-01 Gonella Jacques (Director) Sale 135,550 2.65 358,090
2018-05-30 Gonella Jacques (Director) Sale 100,000 2.55 254,999
2018-05-23 Gonella Jacques (Director) Sale 194,682 2.52 489,625
2018-05-22 Gonella Jacques (Director) Sale 5,318 2.53 13,454
2018-05-18 Gonella Jacques (Director) Sale 21,062 2.60 54,761
2018-05-17 Gonella Jacques (Director) Sale 100,000 2.55 254,999
2018-05-16 Gonella Jacques (Director) Sale 100,000 2.52 252,000
2018-05-15 Gonella Jacques (Director) Sale 100,000 2.50 250,000
2018-05-14 Gonella Jacques (Director) Sale 100,000 2.50 250,000
2018-05-11 Gonella Jacques (Director) Sale 100,000 2.47 247,000
2018-05-11 Apple Robert F (President & CEO) Option Ex 82,500 .85 70,125
2018-05-10 Gonella Jacques (Director) Sale 100,000 2.36 236,000
2018-05-09 Gonella Jacques (Director) Sale 300,000 2.47 740,400
2018-05-03 Gonella Jacques (Director) Option Ex 30,000 .85 25,500
2018-03-29 Jacob Leonard S (Director) Option Ex 32,407 .85 27,545
2017-12-27 Apple Robert F (President & CEO) Option Ex 60,000 1.23 73,800
2017-10-09 Jacob Leonard S (Director) Sale 230,000 4.05 931,730
2017-10-09 Jacob Leonard S (Director) Option Ex 218,600 .68 147,555
2017-10-03 Garrity Thomas J (Director) Sale 30,000 3.50 105,000
2017-10-03 Garrity Thomas J (Director) Option Ex 30,000 .85 25,500
2017-06-09 Powell Fred M (Senior Vice President & CFO) Buy 130,000 2.79 363,220
2017-04-05 Apple Robert F (President & CEO) Sale 3,000 3.00 9,000
2017-04-05 Apple Robert F (President & CEO) Option Ex 3,000 1.65 4,950
2017-04-04 Apple Robert F (President & CEO) Sale 37,000 3.00 111,073
2017-04-04 Apple Robert F (President & CEO) Option Ex 37,000 1.65 61,050
2017-04-04 Jacob Leonard S (Director) Sale 21,762 2.90 63,109
2017-04-04 Jacob Leonard S (Director) Option Ex 21,762 1.65 35,907
2017-04-03 Jacob Leonard S (Director) Sale 20,000 2.88 57,580
2017-04-03 Jacob Leonard S (Director) Option Ex 20,000 1.65 33,000
2017-03-31 Garrity Thomas J (Director) Sale 30,000 2.91 87,270
2017-03-31 Garrity Thomas J (Director) Option Ex 30,000 1.65 49,500
2017-03-31 Gonella Jacques (Director) Option Ex 30,000 1.65 49,500
2016-12-09 Powell Fred M (Senior Vice President & CFO) Buy 100,000 2.02 202,500
2016-03-21 Graham Peter J (SVP General Counsel, Secretary) Buy 20,000 .77 15,400
2016-03-18 Fickenscher James E (Senior Vice President & CFO) Buy 135,000 .72 97,200
2016-03-18 Garrity Thomas J (Director) Buy 30,000 .72 21,600
2016-03-18 Gueth Anton (Director) Buy 50,000 .72 36,000
2016-03-18 Roche Robert P Jr (Director) Buy 50,000 .72 36,000
2016-03-18 Gonella Jacques (Director) Buy 100,000 .72 72,000
2016-03-18 Apple Robert F (President & CEO) Buy 60,000 .72 43,200
2016-03-18 Jacob Leonard S (Director) Buy 50,000 .72 36,000
2016-03-18 Samson Marvin (Director) Buy 50,000 .72 36,000
2015-12-16 Gonella Jacques (Director) Option Ex 20,000 1.54 30,800
2015-09-30 Deerfield Special Situations Fund, L.p. Sale 249,998 1.69 422,996
2015-09-29 Deerfield Special Situations Fund, L.p. Sale 225,048 1.82 409,362
2015-09-28 Deerfield Special Situations Fund, L.p. Sale 1,353,483 1.81 2,447,097
2015-08-24 Roche Robert P Jr (Director) Buy 5,000 1.77 8,850
2015-08-13 Roche Robert P Jr (Director) Buy 5,000 1.94 9,700
2015-07-20 Deerfield International Master Fund, L.p. Sale 106,024 2.13 225,407
2015-07-17 Deerfield International Master Fund, L.p. Sale 125,769 2.20 277,069
2015-07-08 Deerfield International Master Fund, L.p. Sale 444,341 2.05 912,232
2015-07-07 Deerfield International Master Fund, L.p. Sale 198,651 2.09 414,783
2015-07-06 Deerfield International Master Fund, L.p. Sale 191,513 2.12 406,007
2015-07-01 Deerfield International Master Fund, L.p. Sale 43,836 2.11 92,318
2015-06-30 Deerfield International Master Fund, L.p. Sale 608,691 2.08 1,266,685
2015-06-29 Deerfield International Master Fund, L.p. Sale 60,695 2.18 132,072
2015-06-26 Deerfield International Master Fund, L.p. Sale 318,534 2.24 714,790
2015-06-25 Deerfield International Master Fund, L.p. Sale 175,200 2.25 394,200
2015-06-24 Deerfield International Master Fund, L.p. Sale 263,118 2.31 607,539
2015-06-23 Deerfield International Master Fund, L.p. Sale 181,862 2.35 427,193
2015-06-22 Deerfield International Master Fund, L.p. Sale 176,483 2.41 424,618
2015-06-19 Deerfield International Master Fund, L.p. Sale 141,550 2.41 340,569
2015-06-18 Deerfield International Master Fund, L.p. Sale 210,701 2.48 522,117
2015-06-17 Deerfield International Master Fund, L.p. Sale 53,605 2.40 128,920
2015-06-16 Deerfield International Master Fund, L.p. Sale 214,060 2.40 514,386
2015-06-15 Deerfield International Master Fund, L.p. Sale 190,141 2.40 456,718
2015-06-12 Deerfield International Master Fund, L.p. Sale 218,617 2.43 530,364
2015-06-11 Deerfield International Master Fund, L.p. Sale 339,272 2.47 839,019
2015-03-23 Jacob Leonard S (Director) Sale 19,100 2.68 51,188
2015-03-20 Jacob Leonard S (Director) Sale 4,400 2.69 11,836
2014-12-30 Gonella Jacques (Director) Option Ex 20,000 1.40 28,000
2014-12-11 Fickenscher James E (Senior Vice President & CFO) Buy 40,000 2.50 99,800
2014-09-10 Hobbs Eamonn P (President and CEO) Buy 9,000 2.20 19,800
2014-08-13 Roche Robert P Jr (Director) Buy 5,000 1.96 9,795
2014-08-11 Garrity Thomas J (Director) Buy 5,000 1.98 9,900
2014-08-11 Gueth Anton (Director) Buy 5,000 2.00 10,000
2014-08-11 Jacob Leonard S (Director) Buy 10,000 1.98 19,800
2014-08-11 Samson Marvin (Director) Buy 25,000 2.00 49,900

Insider trading activities including stock purchases, stock sales, and option exercises of AIS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Antares Pharma, Inc. (symbol AIS, CIK number 1016169) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.